Dublin, Ireland 9/3/09—Health care products company Covidien has ceased marketing for sale its Specialty Chemicals business, which includes Mallinckrodt Baker, a provider of laboratory chemicals and reagents. The company will reclassify the business as a continuing operation within its Pharmaceuticals segment.
Cambridge, MA 9/3/09—Next-generation sequencer developer Helicos BioSciences has engaged Thomas Weisel Partners to assist in its strategic evaluation and execution of strategic alternatives. The company is currently engaged in discussions with potential partners both inside and outside the genetic sequencing market regarding strategic alternatives, including equity financing and other funding sources, such as partnerships. (For […]
Holliston, MA 9/3/09—Harvard Bioscience has acquired substantially all of the assets of Denville Scientific and assumed certain of the company’s liabilities. The purchase price is expected to be $23–$24 million, depending on Denville’s 2009 financial results. Denville is a distributor of molecular biology products, with a focus on liquid handling items. In 2008, Denville had […]
Santa Clara, CA 9/8/09—Cell Biosciences has agreed to acquire Alpha Innotech for $1.50 per share (a 70.5% premium over the September 4 price), or $17.9 million in cash, and the assumption of $2.1 million in debt. Alpha Innotech provides digital imaging systems, including gel documentation systems. Based in San Leandro, California, the company reported 2008 […]
Waltham, MA and Shanghai, China 9/8/09; Chennai, India 9/8/09—PerkinElmer has acquired companies in India and China to expand its diagnostics business. PerkinElmer acquired SYM-BIO Lifescience, a Chinese provider of diagnostics instruments and related reagents, which specializes in the area of infectious diseases, for $63.7 million in cash. The acquisition doubles PerkinElmer’s access to hospitals in […]
Waltham, MA 9/2/09; Henningsdorf, Germany 9/3/09—Thermo Fisher Scientific has agreed to purchase B.R.A.H.M.S. AG for €330 million ($470 million), including debt and liabilities. B.R.A.H.M.S. provides specialty in vitro diagnostic tests based on biomarkers for sepsis, cardiovascular and pulmonary diseases, as well as intensive care treatments and prenatal screening. B.R.A.H.M.S. offers tests and instrumentation for laboratory […]
Waltham, MA 9/15/09—Thermo Fisher Scientific has appointed Chief Operating Officer Marc N. Casper president, CEO and director, effective October 15. He replaces Marijn E. Dekkers, Thermo’s president and CEO since 2002 (see IBO 11/30/02), who will resign to become CEO of Bayer AG, starting October 1, 2010. “Marc’s strong leadership at Thermo Fisher over the […]
Washington, DC 9/2/09; Toronto, Canada 9/2/09; Carlsbad, CA 9/2/09—Danaher has signed a definitive agreement to purchase MDS’s Analytical Technologies division, which includes MDS’s 50% MS joint venture with Life Technologies and its Bioresearch and Drug Discovery product lines. Danaher has also agreed to purchase Life Technologies’ 50% interest in the joint venture. The aggregate purchase […]
Wilmington, DE 8/13/09—Life Technologies has filed a patent infringement action against Bio-Rad Laboratories in the US District Court for the District of Delaware. The law suit alleges infringement of four patents: US Patent Nos. 6,703,484; 7,223,566; 7,259,242 (each entitled “Methods for Production of Proteins”); and 7,265,206 (entitled “Methods of Production of Proteins”). The complaint alleges […]
Billerica, MA and Austin, TX 8/11/09—Millipore will distribute Luminex’s FLEXMAP 3D system for research applications. “Millipore has an extensive global reach that covers academic, reference and pharmaceutical research laboratories, and we are excited to have the company as a distribution partner for the groundbreaking FLEXMAP 3D instrument,” stated Darin Leigh, vice president of Sales and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
